Tue, Jul 22, 2014, 5:32 AM EDT - U.S. Markets open in 3 hrs 58 mins

Recent

% | $
Click the to save as a favorite.

Lotus Pharmaceuticals, Inc. Message Board

  • lightbluffer lightbluffer Mar 31, 2010 7:22 PM Flag

    Can anyone explain the results in laymens terms?

    Can anyone? I read a little into it....but i'm a little lost. Were they disapointing, in line with estimates, or positive?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • LTUS drops more than I thought it would. Dilution is what people fear right now. I am not adding yet, mainly my current cost basis is low

    • Q4 is history . The quarter was not great but remember last year's Q4 got a boost due to delays in Q3 from the olympics. Now your in Q2 with Q1 over with contracts from an extra 500 drug stores in Beijing going against weak comps of 2009.Ltus just added 22m in equity for 2009, if they repeat that will put 2010 book at 1.75 fully dil.
      with earnings between .45 - .55 ,
      stock price , 2.5 - 3 .

      • 1 Reply to licorice073154
      • I'm a shareholder and I'm concerned. Revenues are down from last year. It appears the main is an increase in competition (see Revenue in revenue section). The pharm. biz has exploded in china over the last 2 to 3 years which means you have a lot more players coming in. I know they (CEO) said $150M in sales after full operaiton of new facility. I'm wondering if these projections have been supported by analysts who know this market better than me. just my 2 cents

    • from the filing:

      Net Income

      As a result of these factors, we reported net income of $16,432,294 for the year ended December 31, 2009 as compared to net income of $12,790,648 for the year ended December 31, 2008. This translated to basic and diluted net income per common share of $0.37, $0.33 and $0.30, $0.27 for the years ended December 31, 2009 and 2008, respectively.

      This is not bad considering. They've increased net earnings compared to the last year results.
      I hope we go up tomorrow.
      If we are going down, I'll be adding to my position. This is nall net positive.

      • 1 Reply to tmduplex
      • this is good over-all since they have a better handle of their A/R's. What I am most interested to see is the follow-up of the earnings report, forward guidance to 2010-2011 and Nasdaq listing if that is even going to happen.

        Somebody mentioned about BSPM.ob. I agree with that comment, LTUS.ob should be trading in the same range. Net-net, LTUS.ob is better than BSPM.ob. This stock way too undervalued.

        This year is going to be pretty interesting for LTUS.ob. Whether the stock goes up or down, I am adding more shares as I see it fit. I am in for the long haul on this one, same thing I did on CNEH.ob, NEP now on Amex.

        Sentiment: Strong Buy (LONG)

    • The results is a mix - some good & some not too good.

      Brought in a lot of cash ($1.4m)
      Paid off some tax (good)
      Overall equity is up (good)
      Net revenue is 18m compared to $14.5m in Q3
      But net income is down to 2.7m from 5.4m
      Therefore, EPS is only 0.05 vs 0.11

      The lower EPS typically cause the stock price to drop in most cases. Since LTUS is already priced pretty low, it might not drop much. If it does drop, it should bounce back quickly.

      Operating cash flow (6.1m) is pretty good for the quarter.
      Net increase in cash is 2.6m, which is more than double from the total of the first 9 months.

      My opinion is overall this is pretty good. The rest depends on guidance and CC.

    • Mixed- they earned less (under 3 mil net income) but their balance sheet is improved/larger- they managed to get a lot of cash from accounts receivable.

      Salaries are half of last year-

      The P/E for 2009 ends being about 4.5

 
LTUS
0.0150.000(0.00%)Jul 18 11:02 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.